Vetoquinol: Availability of the 2021 Universal Registration Document
22 Avril 2022 - 5:45PM
Business Wire
Regulatory News:
Vetoquinol (Paris:VETO) informs that it has filed its 2021
Universal Registration Document with the Autorité des Marchés
Financiers (AMF) on April 22th, 2022.
The 2021 Universal Registration Document is available to the
public, free of charge under the conditions provided by applicable
regulations and may be consulted on the “Investors” page of the
Group’s website (www.vetoquinol.com), in the “Regulated
Information” section. It is also available on the AMF’s website
(www.amf-france.org).
The 2021 Universal Registration Document includes:
- the 2021 Annual Financial Report;
- the Management Report;
- the Board of Directors Report on Corporate Governance;
- the Extra-Financial Performance Declaration;
- the information related to the fees paid to the Statutory
Auditors;
- the share buyback program description; and
- the agenda and draft resolutions of the Shareholder’s Meeting
of May 19th, 2022.
Next update: Q2 2022 Sales, July 20th, 2022 (after market
close)
ABOUT VETOQUINOL
Vetoquinol is a leading global animal health company that
supplies drugs and non-medicinal products for the farm animals
(cattle and pigs) and pets (dogs and cats) markets.
As an independent pure player, Vetoquinol designs, develops and
sells veterinary drugs and non-medicinal products in Europe, the
Americas and the Asia Pacific region.
Since its foundation in 1933, Vetoquinol has pursued a strategy
combining innovation with geographical diversification. The Group’s
hybrid growth is driven by the reinforcement of its product
portfolio coupled with acquisitions in high potential growth
markets.
Vetoquinol employed 2,546 people as of December 31th, 2021.
Vetoquinol has been listed on Euronext Paris since 2006 (symbol:
VETO).
The Vetoquinol share is eligible for the French PEA and PEA-PME
personal equity plans.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220422005344/en/
FOR MORE INFORMATION, CONTACT:
VETOQUINOL
Investor Relations Fanny Toillon Tel.: +33 (0)3 84
62 59 88 relations.investisseurs@vetoquinol.com
KEIMA COMMUNICATION
Investor & Media Relations Emmanuel Dovergne
Tel.: +33 (0) 1 56 43 44 63 emmanuel.dovergne@keima.fr
Vetoquinol (EU:VETO)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Vetoquinol (EU:VETO)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024